CClinicalTrials.gg
CompletedNCT03863340Updated Mar 5, 2019

Short Interventions to Prevent Trapezius Muscle Fatigue in Computer Work

An interventional study of interruptions of work tasks in Muscle Fatigue and Trapezius Muscle Strain, sponsored by Swiss Federal Institute of Technology. Completed. Open to participants aged 18 Years to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-03-05.

Sponsored by Swiss Federal Institute of Technology · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Registered 2 years 9 months after the study started (first participant enrolled Mar 2016, registered Dec 2018).
Phase
Not applicable
Study type
Interventional
Enrollment
30
Ages
18 Years to 40 Years
Sex
All
01

Study summary

This study is expected to demonstrate that during experimental days of seated computer work sustained and focalized low-level muscle activity contributes to the development of long-lasting fatigue effects (and thus possible disorder). On days with and without frequent interruptions, signs of fatigue and the activity pattern of the trapeze muscle are registered and compared using electromyographic registrations of the trapezius muscle.

Read the detailed description

30 healthy adults without chronic neck pain participated in a laboratory study designed to simulate two full workdays of computer work. Within each session, participants performed five 50-min working activities separated by 10-min breaks: i) Use a computer keyboard to type a text presented on the left side of the screen; ii) do the typing task with the desk height set10 cm above elbow height; iii) play the computer game Spider Solitaire implemented in Windows 10; iv) Stroop test (This test consists of reading the name of a color whose text is in a color different from the name. The color name was then selected from a multiple-choice panel displaying color names; v) the same online puzzle game was presented to all participants. Assembling the puzzle was performed by drag and drop actions. The work periods were not disrupted (on the "control day") whereas two short interruptions of 5-min were introduced at 1/3 and 2/3 of each working period on the "intervention day". During these interruptions, participants were asked to perform "muscle disrupting/relaxing" activities. For each experimental session a 30-min lunch break took place between the third and the fourth work periods. The specific sequence of work activity type and disrupting/relaxing activities was randomized across participants; however, for each participant the order of work activities remained the same for the two experimental sessions (control and intervention days). The order of control and intervention days was also randomized between participants.

A set of six measures were performed at specific time intervals during each experiment: before the first work activity, before and after lunch, immediately and 1 hour after the fifth (last) work activity: i) upper trapezius activation, assessed through the temporal EMG profile recorded by a single bipolar signal; and ii) through the spatio-temporal distribution of EMG activity detected by a 2D array of electrodes (64 channels); iii) muscle fatigue, quantified by changes in electrically induced muscle twitch force signals, iv) isometric performance, v) dynamic performance; iii) cognitive and physical load and stress level. In addition, personality traits (anxiety level), perceived workload and musculoskeletal symptoms were evaluated as covariates.

02

Conditions studied

  • Muscle Fatigue
  • Trapezius Muscle Strain

Browse trials for

Keywords

  • muscle fatigue
  • work-related disorders
  • trapezius myalgia
  • sustained working task
  • high-density EMG
03

In context

Fatigue

1,863 studies on the registry are indexed under Fatigue; 377 are open to participants now.

This study's enrollment of 30 is below the median of 54 across 1,443 interventional studies indexed under Fatigue.

Browse Fatigue studies →

Lead sponsor

Swiss Federal Institute of Technology is the lead sponsor of 152 studies on the registry; 10 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 40 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • healthy experienced computer workers

Exclusion criteria

Exclusion Criteria:

  • chronic pain (more than 30 days within the last 12 months according to the Nordic Questionnaire (Kuorinka et al 1987);
  • pathologies of the neck,
  • prior and actual shoulder or neck pain caused by an accident,
  • skin disease in the neck or shoulder area,
  • BMI > 30,
  • sleep disorders (e.g. apnea, restless legs syndrome),
  • use of medications such as psychotropic drugs, muscle relaxants or analgesics within the last 3 days prior to the experiment,
  • pregnancy.
  • any shoulder/neck pain on the day before the experiment.
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Intervention model
Sequential assignment
Masking
None (open label)
Enrollment
30 participants (actual)

Study arms

  • Experimental
    short interruptions of work tasks

    randomly start with or without short interruptions on the first experimental day and without or with them on the second experimental day

    Behavioral: interruptions of work tasks

Interventions

  • Behavioralinterruptions of work tasks

    During each activity two interruptions/breaks were selected randomly from a set of ten predetermined actions: Active break types: * Move shoulder and upper back * Swing arms near the body * Three slow but forceful elevations of the shoulders, a relaxation exercise based on the principles developed by Jacobson * Stand up and stretch * Slowly turn head in all possible directions. Passive break types: * Tell a couple of jokes * Stand up and have a drink * Relaxing the trapezius * Questions on actual posture and feelings of comfort / discomfort. * A short rest on the couch

06

What researchers measure

Primary outcomes

  1. EMG profile recorded by a single bipolar electrode: Rest-time

    Rest-time (percentage of time below 5% of the standard activity level). The percentage of registration time without any rest time is called sustained low level muscle activity.

    Time frame: Continuously from the beginning to 370 min (end) of the simulated working activity of both the control and intervention day

  2. Spatio-temporal distribution of EMG activity: Area of muscle activity

    The spatio-temporal distribution of EMG activity is detected by a 2D array of electrodes (64 channels) and the following outcomes are determined: Area of muscle active region (n. of channels)

    Time frame: Continuously from the beginning to 370 min (end) of the simulated working activity of both the control and intervention day

  3. Muscle fatigue: Change of muscle twitch

    3-D muscle twitch acceleration pattern measured at the acromion

    Time frame: Change between 30 min before the beginning of the simulated working activity and 30 min after the end of the simulated working activity of both the control and intervention day

  4. Muscle fatigue: Change of dynamic force control accuracy

    Force control accuracy (mean squared error between the produced force (N) and the target force (N)) in an isometric dynamic tracking task

    Time frame: Change between 30 min before the beginning of the simulated working activity and 30 min after the end of the simulated working activity of both the control and intervention day

Secondary outcomes

  1. EMG profile recorded by a single bipolar electrode: Static activity

    p10 (level of the 10th percentile of the trapezius muscle activity) as an indicator of static activity primarily associated with continuous activity of the same pool of motor units.

    Time frame: Continuously from the beginning to 370 min (end) of the simulated working activity of both the control and intervention day

  2. Spatio-temporal distribution of EMG activity: Magnitude of activity

    The spatio-temporal distribution of EMG activity is detected by a 2D array of electrodes (64 channels) and the following outcomes are determined: Magnitude of activity of muscle active regions (RMS sEMG).

    Time frame: Continuously from the beginning to 370 min (end) of the simulated working activity of both the control and intervention day

  3. Spatio-temporal distribution of EMG activity: Number of active epochs

    The spatio-temporal distribution of EMG activity is detected by a 2D array of electrodes (64 channels) and the following outcomes are determined: Number of active epochs

    Time frame: Continuously from the beginning to 370 min (end) of the simulated working activity of both the control and intervention day

  4. Muscle fatigue: Change of static force control

    Force control accuracy (mean squared error between the produced force (N) and the target force (N)) in isometric isotonic low level contraction

    Time frame: Change between 30 min before the beginning of the simulated working activity and 30 min after the end of the simulated working activity of both the control and intervention day

  5. Muscle fatigue: Change of force control in ramp contraction

    Force control accuracy (mean squared error between the produced force (N) and the target force (N)) in isometric ramp contraction.

    Time frame: Change between 30 min before the beginning of the simulated working activity and 30 min after the end of the simulated working activity of both the control and intervention day

Other outcomes

  1. Localized musculoskeletal discomfort

    head-neck-shoulders-lower back-elbows-wrists-hip-upper legs-knees-ankles-feet-discomfort rated on 10 cm visual analog scales (adapted from Nordic questionnaire (Kuorinka et al 1987)

    Time frame: At the start, and 70min, 130min, 190min, 310min, 370 min after the beginning of the simulated working activity of both the control and intervention day

  2. Visual and general fatigue

    10 cm visual analog scales

    Time frame: At the start, and 70min, 130min, 190min, 310min, 370 min after the beginning of the simulated working activity of both the control and intervention day

  3. Effort

    6-20 Borg scale (6= no effort, 20=maximal possible effort)

    Time frame: At the start, and 70min, 130min, 190min, 310min, 370 min after the beginning of the simulated working activity of both the control and intervention day

  4. EMG profile recorded by a single bipolar electrode: Dynamic activity

    p90 (level of the 90th percentile of the trapezius muscle activity) as an indicator of dynamic activity which may promote variability in the recruitment of motor units

    Time frame: Continuously from the beginning to 370 min (end) of the simulated working activity of both the control and intervention day

  5. Spatio-temporal distribution of EMG activity: Centroid of active regions

    The spatio-temporal distribution of EMG activity is detected by a 2D array of electrodes (64 channels) and the following outcomes are determined: Centroid of active regions

    Time frame: Continuously from the beginning to 370 min (end) of the simulated working activity of both the control and intervention day

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 5, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03863340
Lead sponsor
Swiss Federal Institute of Technology
Collaborators
University of Turin, Italy, University of Lausanne, University of Michigan
Responsible party
Sponsor
First posted
Mar 5, 2019
Start date
Mar 14, 2016
Primary completion
Sep 5, 2016
Completion
Sep 5, 2016
Last update
Mar 5, 2019

Study contacts

Thomas Läubli, MD
principal investigator · Federal Institute of Technology Zurich

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion